Skip to main content

Table 2 Baseline characteristics for intervention and control group – the NILS feasibility study

From: A lifestyle intervention among elderly men on active surveillance for non-aggressive prostate cancer: a randomised feasibility study with whole-grain rye and exercise

  Intervention (n = 14) Control (n = 7)
  Mean (SD) Mean (SD)
Age at baseline (y) 63 (5) 63 (5)
Age at PC diagnosis (y) 61 (6) 63 (6)
Weight (kg) 88 (17) 83 (10)
Height (m) 1.83 (0.06) 1.80 (0.04)
BMI (kg/m2) 26.0 (3.4) 25.6 (2.5)
Hip circumference (cm) 105 (10) 102 (6)
Waist circumference (cm) 102 (15) 98 (6)
Fat-free mass (kg) 65 (7) 64 (6)
Fat mass (%) 25 (6) 23 (4)
VO2 max (ml O2/min/kg) 29 (7) 26 (5)
Systolic BP (mmHg) 146 (19) 142 (13)
Diastolic BP (mmHg) 89 (10) 87 (8)
HDL cholesterol (mmol/L) 1.3 (0.2) 1.3 (0.2)
LDL cholesterol (mmol/L) 2.8 (0.7) 2.9 (0.6)
Total cholesterol (mmol/L) 5.1 (0.7) 5.3 (0.8)
Triglycerides (mmol/L) 1.3 (0.4) 1.5 (0.6)
Fasting plasma glucose (mmol/L) 5.8 (0.6) 6.1 (0.4)
Fasting blood glucose (mmol/L) 5.3 (0.5) 5.6 (0.5)
Blood glucose 2 h (mmol/L) 6.7 (2.2) 8.3 (2.0)
Fasting insulin (mmol/L) 11.6 (6.6) 11.8 (6.8)
Alkylresorcinols total (nmol/L) 109 (98) 74 (39)
C17:C21 alkylresorcinol ratio 0.39 (0.19) 0.30 (0.10)
Plasma enterolactone (nM) 51 (51) 52 (50)
Prostate-specific antigen (PSA) (ng/ml) 5.4 (1.7) 5.0 (2.2)
  1. SD standard deviation, PC prostate cancer, BMI body mass index, VO 2 max peak oxygen consumption per unit time, BP blood pressure, HDL high-density lipoprotein, LDL low-density lipoprotein